dc.contributor.author |
Bedke, Jens |
|
dc.date.accessioned |
2021-08-04T08:51:06Z |
|
dc.date.available |
2021-08-04T08:51:06Z |
|
dc.date.issued |
2021 |
|
dc.identifier.issn |
1533-4406 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/117687 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Massachusetts Medical Soc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1056/NEJMoa2026982 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20210512015105_00473 |
|
utue.publikation.seiten |
829-841 |
de_DE |
utue.personen.roh |
Choueiri, T. K. |
|
utue.personen.roh |
Powles, T. |
|
utue.personen.roh |
Burotto, M. |
|
utue.personen.roh |
Escudier, B. |
|
utue.personen.roh |
Bourlon, M. T. |
|
utue.personen.roh |
Zurawski, B. |
|
utue.personen.roh |
Juarez, V. M. Oyervides |
|
utue.personen.roh |
Hsieh, J. J. |
|
utue.personen.roh |
Basso, U. |
|
utue.personen.roh |
Shah, A. Y. |
|
utue.personen.roh |
Suarez, C. |
|
utue.personen.roh |
Hamzaj, A. |
|
utue.personen.roh |
Goh, J. C. |
|
utue.personen.roh |
Barrios, C. |
|
utue.personen.roh |
Richardet, M. |
|
utue.personen.roh |
Porta, C. |
|
utue.personen.roh |
Kowalyszyn, R. |
|
utue.personen.roh |
Feregrino, J. P. |
|
utue.personen.roh |
Zolnierek, J. |
|
utue.personen.roh |
Pook, D. |
|
utue.personen.roh |
Kessler, E. R. |
|
utue.personen.roh |
Tomita, Y. |
|
utue.personen.roh |
Mizuno, R. |
|
utue.personen.roh |
Bedke, J. |
|
utue.personen.roh |
Zhang, J. |
|
utue.personen.roh |
Maurer, M. A. |
|
utue.personen.roh |
Simsek, B. |
|
utue.personen.roh |
Ejzykowicz, F. |
|
utue.personen.roh |
Schwab, G. M. |
|
utue.personen.roh |
Apolo, A. B. |
|
utue.personen.roh |
Motzer, R. J. |
|
dcterms.isPartOf.ZSTitelID |
New England Journal of Medicine |
de_DE |
dcterms.isPartOf.ZS-Issue |
9 |
de_DE |
dcterms.isPartOf.ZS-Volume |
384 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |